Iftar Timings Mar 19 - Ramazan 8

Lahore
LHR
06:14 PM
Karachi
KHI
06:43 PM
Islamabad
ISB
06:19 PM
Peshawar
PWR
06:23 PM
Quetta
QTA
06:43 PM

News

AstraZeneca files for EU vaccine approval

January 12, 2021 06:43 PM


AstraZeneca and Oxford University have applied for authorisation for their coronavirus vaccine in the EU with a decision possible by January 29, the European Medicines Agency said on Tuesday.

The jab would be the third available for the 27-nation European Union after the Pfizer-BioNTech and Moderna drugs, as the bloc struggles to speed up the rollout.

"EMA has received an application for conditional marketing authorisation for a COVID-19 vaccine developed by AstraZeneca and Oxford University," the Amsterdam-based regulator said in a statement.

The EMA said its assessment would "proceed under an accelerated timeline".

"An opinion on the marketing authorisation could be issued by 29 January... provided that the data submitted on the quality, safety and efficacy of the vaccine are sufficiently robust and complete," it said.

The EU and the EMA have been under pressure to speed up approval of new vaccines against the virus, which has claimed the lives of more than 620,000 people across the continent. 

European Commission chief Ursula von der Leyen hailed the application by Oxford-AstraZeneca as "good news".

"Once the vaccine receives a positive scientific opinion, we will work full speed to authorise its use in Europe," she said on Twitter.

The Oxford-AstraZeneca jab is cheaper to produce than its rivals, and easier to store and transport than the Pfizer-BioNTech vaccine in particular, which requires ultra-low freezing temperature.

It is based on a weakened version of a common cold virus (adenovirus) in chimpanzees which has been genetically changed to stop Covid-19 replicating in humans.

Oxford-AstraZeneca has previously been criticised over a lack of clarity and transparency on trials that had shown varying outcomes in the jab's efficiency.

Initial large-scale trials in which volunteers in the UK and Brazil were given two full doses showed 62 percent effectiveness.

For volunteers who received a half-dose first and then a full dose one month later, however, the vaccine was found to have 90 percent efficacy.

The EMA said it had already been reviewing data from "four ongoing clinical trials" in Britain, Brazil and South Africa.

"Additional scientific information on issues related to quality, safety and efficacy of the vaccine was also provided by the company at the request of (the EMA) and is currently being assessed," it added.

 

 



Most Read

  1. Google invites Pakistan’s youngest vlogger Shiraz and sister Muskan to USA Google invites Pakistan’s youngest vlogger Shiraz and sister Muskan to USA
  2. Well-known builder Asif Razaq Deenar arrested at Karachi airport Well-known builder Asif Razaq Deenar arrested at Karachi airport
  3. Islamabad players celebrate victory with Palestine flag Islamabad players celebrate victory with Palestine flag
  4. Caught in the act: Corrupt cops fired as video goes viral Caught in the act: Corrupt cops fired as video goes viral
  5. Religious Brotherhood: Tharparkar’s Hindu facilitiates Muslim in Ramazan Religious Brotherhood: Tharparkar’s Hindu facilitiates Muslim in Ramazan
  6. Ahmed Baig delivers Pakistan's first International Golf Victory in more than 25 years Ahmed Baig delivers Pakistan's first International Golf Victory in more than 25 years

Opinion

  1. 1947 TO FORM 47
    1947 TO FORM 47

    By Dr Asif Channer

  2. Beijing wants to further highlight industrial sector in its country and take scientific innovation to new heights....
    Beijing wants to further highlight industrial sector in its country and take scientific innovation to new heights....

    By Ali Ramay

  3. Global race: China will reduce its unnecessary expenses
    Global race: China will reduce its unnecessary expenses

    By Ali Ramay

  4. Channer Pir: The Great Saint of Cholistan
    Channer Pir: The Great Saint of Cholistan

    By Dr Asif Channer

  5. Literate the Religious Illiterate
    Literate the Religious Illiterate

    By Dr Asif Channer

  6. From White Elephant to Success: BRI Project Witnesses Surge in Ridership
    From White Elephant to Success: BRI Project Witnesses Surge in Ridership

    By Ali Ramay